期刊文献+

血清胱抑素C对高血压早期肾功能减退的临床价值 被引量:6

Clinical value of serum Cys-C in patients with renal insufficiency at the early stage of hypertension
下载PDF
导出
摘要 目的探讨血清胱抑素C(Cys-C)水平对高血压早期肾功能减退的临床价值。方法根据血压情况,将61例研究对象分为3组:对照组、血压控制组和血压升高组,测定血清Cys-C、尿素氮(Bun)和肌酐(Cr)并进行对比分析。结果 3组间Cys-C测定值及Cys-C阳性率有统计学差异(P<0.01),而收缩压(SBP)、舒张压(DBP)、Bun及Cr值无显著性差异。结论 Cys-C是高血压早期肾功能减退的重要诊断指标之一,较Bun和Cr更敏感,有助于早期预测肾功能减退。 Objective To analyze the clinical value of serum Cys-C in patients with renal insufficiency at the early stage of hypertension.Methods According to blood pressure,61 patients were divided into three groups:control group,blood pressure baseline group and blood pressure uncontrolled group.Serum Cys-C,blood urea nitrogen(Bun)and creatinine(Cr)were determined and the data were compared and analyzed.Results The levels and positive rate of serum Cys-C were significantly different among three groups(P0.01),but there were no significant differences in the levels of Bun and Cr among three groups.Conclusions Serum Cys-C plays an important role in patients with renal insufficiency at the early stage of hypertension.It is more sensitive than Bun and Cr.It contributes to predicting the renal insufficiency at the early stage.
作者 杨楠
出处 《实用老年医学》 CAS 2010年第6期513-514,共2页 Practical Geriatrics
关键词 血清胱抑素C 高血压 肾功能减退 serum Cystatin C hypertension renal insufficiency
  • 相关文献

参考文献8

二级参考文献42

  • 1孙红,陈莎,段艺,艾洪武,胡红兵,游上游.血清胱抑素C在儿童肾脏疾病中的应用研究[J].微循环学杂志,2005,15(4):31-32. 被引量:40
  • 2蔡钢强,垢敬,焦连亭.胱抑素C的生物学特性及临床应用评价[J].国际检验医学杂志,2006,27(5):457-460. 被引量:57
  • 3朱国文.血清胱抑素C在肾脏疾病中的应用评价[J].国际检验医学杂志,2007,28(5):470-471. 被引量:14
  • 4黄向阳,王英,刘倩,罗春娥.血清胱抑素C检测与肾功能关系的临床研究[J].中国实验诊断学,2007,11(6):801-802. 被引量:17
  • 5UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 [ J ]. BMJ, 1998, 317(7160) :703-713.
  • 6Patel A, MacMahon S, Chalmers J, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus ( the ADVANCE trial) : a randomised controlled trial [ J ]. Lancet,2007,370(9590) :829-840.
  • 7Voyaki SM, Staessen JA, Thijs L, et al. Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension [ J ]. J Hypertens,2001,19(3) :511-519.
  • 8Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events [J]. N Engl J Med, 2008, 358 ( 15 ) : 1547-1559.
  • 9Casas JP, Chua W, Loukogeorgakis S, et al. Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and metaanalysis [ J ]. Lancet, 2005, 366 ( 9502 ) : 2026-2033.
  • 10Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes[J]. N Engl J Med,2001,345(12) :851-860.

共引文献132

同被引文献59

引证文献6

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部